Management of NSCLC in Asia Tony Mok MD Professor Dept. of Clinical Oncology] The Chinese University of Hong Kong.
New Strategies on Horizon Tony Mok MD Dept of Clinical Oncology The Chinse University of Hong Kong.
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) in Non-Small Cell Lung Cancer (NSCLC) Victor.
![Management of NSCLC in Asia Tony Mok MD Professor Dept. of Clinical Oncology] The Chinese University of Hong Kong.](https://static.fdocuments.us/doc/330x215/5514329b5503466d1a8b50e0/management-of-nsclc-in-asia-tony-mok-md-professor-dept-of-clinical-oncology-the-chinese-university-of-hong-kong.jpg)
